Among adults hospitalized with influenza, Tamiflu treatment on the day of hospital admission was associated with a reduced risk for disease progression.
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback